Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Systemic Absorption of Sunscreen Ingredients
NCT03582215Phase 1Completed
- Sponsor
- Food and Drug Administration
- Start
- Jul 2018
- Primary completion
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of avobenzone, Oxybenzone, ecamsule, octocrylene, homosalate and 2 more in sunburn (8 arms), sponsored by Food and Drug Administration. Primary endpoint: Avobenzone Maximum Concentration. Started Jul 2018; status: completed.
02
Drugs
avobenzoneOxybenzoneecamsuleoctocrylenehomosalate
03
Conditions
sunburn
Beyond the preview
Go deeper on NCT03582215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03582215.